한국   대만   중국   일본 
đi?u tr? va ki?m soat COVID-19 ? Wikipedia ti?ng Vi?t B??c t?i n?i dung

đi?u tr? va ki?m soat COVID-19

Bach khoa toan th? m? Wikipedia

Hi?n t?i, v?n ch?a co co ph??ng phap ho?c thu?c đ?c tr? hi?u qu? cho b?nh virus corona 2019 (COVID-19), do virus SARS-CoV-2 gay ra. [1] [ C?n c?p nh?t ] [2] Sau m?t n?m k? t? khi đ?i d?ch bung phat, cac v?c-xin co hi?u qu? cao hi?n đa đ??c gi?i thi?u va b?t đ?u lam ch?m s? lay lan c?a SARS-CoV-2; tuy nhien, đ?i v?i nh?ng ng??i đang ch? tiem ch?ng, c?ng nh? đ?i v?i hang tri?u ng??i (con s? ??c tinh) b? suy gi?m mi?n d?ch khong co kh? n?ng đap ?ng m?nh m? v?i tiem ch?ng, vi?c đi?u tr? v?n đong m?t vai tro quan tr?ng. [3] Do v?y, s? thi?u ti?n tri?n trong vi?c phat tri?n cac ph??ng phap đ?c tr? hi?u qu? đ?ng ngh?a v?i vi?c: n?n t?ng c?a vi?c ki?m soat COVID-19 la ch?m soc h? tr? hay đi?u tr? tri?u ch?ng , bao g?m đi?u tr? đ? lam gi?m cac tri?u ch?ng , thay th? d?ch l?ng , li?u phap oxy , thay đ?i t? th? sang n?m s?p khi c?n thi?t, c?ng nh? s? d?ng cac lo?i thu?c ho?c thi?t b? đ? h? tr? nh?ng c? quan thi?t y?u trong c? th?. [4] [5] [6]

H?u h?t cac ca m?c COVID-19 đ?u ch? m?c nh? ho?c v?a. Trong nh?ng tr??ng h?p nay, ch?m soc h? tr? bao g?m s? d?ng thu?c nh? paracetamol ho?c NSAID đ? gi?m cac tri?u ch?ng (s?t, đau nh?c c? th?, ho) c?ng nh? th?c hi?n hi?u qu? cac bi?n phap nh? b? sung d?ch l?ng, ngh? ng?i va th? b?ng m?i. [2] [7] [8] [9] V? sinh ca nhan t?t va m?t ch? đ? ?n u?ng lanh m?nh c?ng đ??c khuy?n khich. [10] Trung tam Ki?m soat va Phong ng?a D?ch b?nh Hoa K? (CDC) khuy?n cao nh?ng ai nghi ng? minh mang virus nen t? cach ly ? nha va đeo kh?u trang. [11]

Nh?ng ng??i v?i bi?u hi?n n?ng h?n co th? s? c?n ph?i đi?u tr? t?i b?nh vi?n. ? nh?ng ng??i co m?c oxy th?p, glucocorticoid dexamethasone đ??c khuy?n ngh? s? d?ng, vi no co th? lam gi?m nguy c? t? vong. [12] [13] [14] Thong khi khong xam l?n va n?ng h?n la, nh?p vi?n khu h?i s?c tich c?c đ? th? may la cac bi?n phap co th? c?n trong h? tr? ho h?p. [15] Trao đ?i oxy qua mang ngoai c? th? (ECMO) đa đ??c s? d?ng đ? gi?i quy?t v?n đ? suy ho h?p, nh?ng l?i ich c?a no v?n đang đ??c xem xet. [16] [17] M?t s? tr??ng h?p b?nh di?n ti?n n?ng la do qua trinh viem nhi?m toan than, đ??c g?i b?ng cai ten la bao cytokine . [18]

M?t s? ph??ng phap đi?u tr? th? nghi?m đang đ??c tich c?c nghien c?u trong cac th? nghi?m lam sang . [1] [1] Co m?t s? ph??ng phap t?ng đ??c cho la co tri?n v?ng s?m trong đ?i d?ch, ch?ng h?n nh? s? d?ng hydroxychloroquine hay lopinavir/ritonavir , nh?ng cac nghien c?u sau đo ch? ra r?ng chung khong th?c s? hi?u qu?, th?m chi la co th? gay h?i. [1] [19] [20] M?c du cac nghien c?u đang đ??c ti?n hanh, v?n ch?a co đ? b?ng ch?ng ch?t l??ng t?t đ? khuy?n ngh? đi?u tr? s?m. [19] [20] Tuy v?y, t?i Hoa K?, hai li?u phap d?a tren khang th? đ?n dong đa co s?n đ? s? d?ng s?m trong nh?ng ca m?c đ??c cho la co nguy c? cao ti?n tri?n thanh b?nh n?ng. [20] Remdesivir v?i kh? n?ng khang virus hi?n đa co s?n ? Hoa K?, Canada, Uc va m?t s? qu?c gia khac, v?i cac h?n ch? s? d?ng khac nhau; tuy nhien, lo?i thu?c khong đ??c khuy?n khich cho nh?ng ng??i c?n th? may va hoan toan khong đ??c khuy?n khich b?i T? ch?c Y t? Th? gi?i (WHO), [21] do b?ng ch?ng h?n ch? v? tinh hi?u qu? c?a no. [1]

M?t s? ng??i co th? g?p cac tri?u ch?ng dai d?ng ho?c tan t?t sau khi ph?c h?i sau ph?i nhi?m; tinh tr?ng nay đ??c g?i la h?i ch?ng COVID keo dai . Nh?ng thong tin v? cach ki?m soat va ph?c h?i t?t nh?t cho nh?ng tr??ng h?p nay v?n con r?t h?n ch?. [15]

WHO, ?y ban Y t? Qu?c gia Trung Qu?c , Vi?n Qu?c gia v? Y t? va Ch?m soc Xu?t s?c V??ng qu?c Anh, va Vi?n Y t? Qu?c gia Hoa K? , cung v?i cac c? quan va t? ch?c khac tren toan th? gi?i, đ?u đa cong b? cac khuy?n ngh? va h??ng d?n ch?m soc ng??i b? COVID?19. [22] [23] [15] [24] Cac nha nghien c?u tri?u ch?ng va cac bac s? chuyen khoa ph?i ? Hoa K? đa t?ng h?p cac khuy?n ngh? đi?u tr? t? cac c? quan khac nhau thanh m?t ngu?n tai li?u mi?n phi, co t?i IBCC . [25] [26]

Cac thu?c ch?a tr? [ s?a | s?a ma ngu?n ]

M?t bac s? gay me ki?t s?c ? Pesaro , Y, thang 3 n?m 2020

đa co m?t s? l??ng l?n cac thu?c đ??c xem xet đ? s? d?ng cho b?nh nhan COVID-19. [27] Tinh đ?n thang 2 n?m 2021, t?i Hoa K?, remdesivir đa đ??c FDA ch?p thu?n cho s? d?ng tren m?t s? b?nh nhan COVID-19, va đa co gi?y phep s? d?ng kh?n c?p cho cac thu?c nh? baricitinib , bamlanivimab , bamlanivimab/etesevimab , va casirivimab/imdevimab . [28] Vao ngay 16 thang 4 n?m 2021, FDA đa thu h?i gi?y phep s? d?ng kh?n c?p (EUA) đ?i v?i li?u phap s? d?ng m?t minh khang th? đ?n dong bamlanivimab đ? đi?u tr? COVID-19 cho b?nh nhan nhi?m COVID-19 ? m?c nh? đ?n trung binh ? ng??i l?n va m?t s? b?nh nhan nhi. [29] T?i lien minh Chau Au , vi?c s? d?ng dexamethasone đa đ??c xac nh?n va thu?c remdesivir đ??c c?p gi?y phep l?u hanh co đi?u ki?n . [30] Dexamethasone cho th?y l?i ich lam sang trong đi?u tr? COVID-19, đ??c xac đ?nh trong cac th? nghi?m ng?u nhien co đ?i ch?ng. [31] [32] Nghien c?u ban đ?u cho th?y tac d?ng c?a remdesivir trong vi?c ng?n ng?a t? vong va rut ng?n th?i gian b? b?nh, nh?ng đi?u nay khong đ??c ch?ng minh b?i cac th? nghi?m sau đo. [1] M?t s? cac thu?c khac nh? budesonide va tocilizumab co cho th?y m?t s? k?t qu? đang h?a h?n nh?ng v?n đang đ??c nghien c?u k? h?n. [33] [34] [35]

Trong nh?ng thang đ?u c?a đ?i d?ch, nhi?u bac s? ? khoa h?i s?c tich c?c khi đ?i m?t v?i tinh ch?t ch?t ng??i c?a virus đa m?o hi?m ke đ?n cac ph??ng phap đi?u tr? b?ng ph?ng đoan vi hoan c?nh ch?a t?ng co c?a đ?i d?ch. [36] Tuy nhien, tieu chu?n quan tam cho h?u h?t cac b?nh kho ch?a la khi c?n b?nh t?n t?i qua nhi?u n?m, cac bac s? s? xay d?ng m?t kh?i l??ng nghien c?u đ? ki?m tra cac ly thuy?t khac nhau, so sanh va đ?i chi?u li?u l??ng c?ng nh? xem xet hi?u qu? c?a m?t lo?i thu?c nay so v?i m?t lo?i thu?c khac. [36]

M?t s? lo?i thu?c khang virus đang đ??c xem xet đ? s? d?ng đ?i v?i COVID-19, m?c du ch?a co lo?i thu?c nao đ??c ch?ng minh la co hi?u qu? ro rang tren t? l? t? vong trong cac th? nghi?m đ?i ch?ng ng?u nhien đa đ??c cong b?. [37] Vi?c s? d?ng huy?t t??ng h?i ph?c nh? m?t l?a ch?n đi?u tr? đa đ??c nghien c?u nh?ng khong cho th?y hi?u qu?. [38] [39] Cac th? nghi?m khac đang đi?u tra xem li?u cac lo?i thu?c hi?n co co th? đ??c s? d?ng hi?u qu? đ? ch?ng l?i ph?n ?ng mi?n d?ch c?a c? th? đ?i v?i vi?c nhi?m SARS-CoV-2 hay khong. [37] [40] Nghien c?u v? cac ph??ng phap đi?u tr? ti?m n?ng đa b?t đ?u t? thang 1 n?m 2020, [41] va m?t s? lo?i thu?c khang virus đang đ??c th? nghi?m lam sang. [42] [43] M?c du co th? c?n đ?n t?n n?m 2021 đ? phat tri?n cac lo?i thu?c m?i, [44] m?t s? lo?i thu?c đang đ??c th? nghi?m đa đ??c phe duy?t cho cac m?c đich s? d?ng khac ho?c đa đang trong qua trinh th? nghi?m nang cao. [45] Thu?c khang virus co th? đ??c th? ? nh?ng ng??i b? b?nh n?ng. [4] WHO khuy?n khich cac tinh nguy?n vien tham gia vao cac cu?c th? nghi?m v? tinh hi?u qu? va an toan c?a cac ph??ng phap đi?u tr? ti?m n?ng. [46]

Cac ph??ng phap khang th? đ?n dong nh? bamlanivimab/etesevimab va casirivimab/imdevimab đa đ??c quan sat la giup gi?m s? ca nh?p vi?n, s? ca c?p c?u va s? ca t? vong. [47] [48] Hai lo?i thu?c k?t h?p nay đa đ??c cho phep s? d?ng kh?n c?p b?i FDA . [47] [48]

S? d?ng m?t s? lo?i thu?c khong ke đ?n nh? paracetamol hay ibuprofen c?ng nh? u?ng đ? n??c va ngh? ng?i h?p ly co th? giup lam gi?m cac tri?u ch?ng. [2] [49] Tuy thu?c vao m?c đ? nghiem tr?ng c?a b?nh, li?u phap oxy va tiem t?nh m?ch c?ng co th? la c?n thi?t. [50]

M?t s? ph??ng phap đi?u tr? thay đ?i b?nh ( disease-modifying ) đa đ??c nghien c?u va phat hi?n ra la khong hi?u qu? ho?c khong an toan, do đo khong đ??c khuy?n khich s? d?ng; chung bao g?m baloxavir marboxil , lopinavir /ritonavir , ruxolitinib , chloroquine , hydroxychloroquine , interferon β-1a va colchicine . [14] Favipiravir va nafamostat đa cho ra cac k?t qu? khac nhau nh?ng v?n đang trong qua trinh th? nghi?m lam sang ? m?t s? qu?c gia. [51] [52] [53]

H? tr? ho h?p [ s?a | s?a ma ngu?n ]

M?t b?nh nhan nguy k?ch đang đ??c thong khi xam nh?p trong phong ch?m soc đ?c bi?t c?a Vi?n Tim, đ?i h?c Sao Paulo, trong đ?i d?ch COVID-19 ? Brazil . Do thi?u may th?, may th? c?u đang đ??c s? d?ng đ? t? đ?ng kich ho?t m?t n? van tui .

Th? may [ s?a | s?a ma ngu?n ]

H?u h?t cac ca m?c COVID-19 khong nghiem tr?ng t?i m?c c?n th? may ho?c cac ph??ng phap ho h?p hay th?, nh?ng v?n co m?t t? l? cac ca c?n đ?n nh?ng bi?n phap nay. [54] va đ?c bi?t la nh?ng ng??i tren 80 tu?i). [55] [56] Ki?u h? tr? ho h?p cho nh?ng ng??i b? suy ho h?p lien quan đ?n COVID-19 đang đ??c tich c?c nghien c?u cho nh?ng ng??i trong b?nh vi?n, v?i m?t s? b?ng ch?ng cho th?y: vi?c đ?t n?i khi qu?n co th? đ??c tranh b?ng cach thong khi l?u l??ng cao qua m?i ho?c thong khi ap l?c d??ng hai m?c . [57] Hai ph??ng phap nay co mang l?i l?i ich nh? nhau cho nh?ng ng??i b? b?nh n?ng hay khong la m?t đi?u v?n con ch?a sang ro. [58] M?t s? bac s? ch?n duy tri th? may xam nh?p khi co th? vi k? thu?t nay giup h?n ch? s? lan truy?n c?a cac gi?t sol khi n?u so v?i thong khi l?u l??ng cao. [54]

Vi?c th? may đa đ??c th?c hi?n ? 79% ng??i b?nh n?ng đang n?m vi?n, trong đo 62% đa nh?n đ??c cac ph??ng phap đi?u tr? khac tr??c đo. T? l? t? vong ? nhom nay la 41%, theo m?t nghien c?u ? Hoa K?. [59]

Cac ca chuy?n bi?n n?ng th??ng đ??c quan sat nhi?u nh?t ? ng??i l?n tu?i (nh?ng ng??i tren 60 tu?i, [54] va đ?c bi?t la nh?ng ng??i tren 80 tu?i). [55] Nhi?u n??c phat tri?n khong co đ? gi??ng b?nh tren đ?u ng?? i, lam h?n ch? n?ng l?c c?a h? th?ng y t? trong vi?c x? ly s? ca COVID-19 t?ng đ?t bi?n đ?n m?c ph?i nh?p vi?n. [60] Chinh s? gi?i h?n trong kh? n?ng l?c h? tr? nay la m?t đ?ng l?c quan tr?ng đ?ng sau nh?ng l?i keu g?i yeu c?u lam ph?ng đ??ng cong . [60] M?t nghien c?u ? Trung Qu?c cho th?y: trong s? 5% b?nh nhan đ??c đ?a vao h?i s?c tich c?c , co 2,3% c?n h? tr? th? may va co 1,4% t? vong. [16] ? Trung Qu?c, kho?ng 30% s? ng??i nh?p vi?n v?i COVID-19 cu?i cung s? đ??c đ?a đ?n đ?n v? h?i s?c tich c?c. [61]

Vi?c s? d?ng nitric oxide d?ng hit cho nh?ng ng??i đang đ??c th? may la khong đ??c khuy?n ngh?, nh?ng b?ng ch?ng y khoa v? ph??ng phap nay hi?n v?n con y?u. [62]

H?i ch?ng suy gi?m ho h?p c?p tinh [ s?a | s?a ma ngu?n ]

V?n đ? th? may tr? nen ph?c t?p h?n khi h?i ch?ng suy ho h?p c?p tinh (ARDS) c?ng ti?n tri?n trong đ?i d?ch COVID-19 va vi?c cung c?p oxy ngay cang tr? nen kho kh?n. [63] May th? v?i kh? n?ng ki?m soat ap su?t va ap l?c d??ng cu?i (PEEP) [64] la c?n thi?t đ? t?i đa hoa vi?c cung c?p oxy đ?ng th?i gi?m thi?u nguy c? t?n th??ng ph?i do may th? va tran khi mang ph?i . [65]

Trao đ?i oxy qua mang ngoai c? th? [ s?a | s?a ma ngu?n ]

Trao đ?i oxy qua mang ngoai c? th? ( Extracorporeal membrane oxygenation , vi?t t?t: ECMO ) la cong ngh? ph?i nhan t?o đ??c ap d?ng t? nh?ng n?m 1980 đ? đi?u tr? suy ho h?p va h?i ch?ng suy ho h?p c?p khi th? may thong th??ng khong thanh cong. Trong ph??ng phap ph?c t?p nay, mau đ??c l?y ra kh?i c? th? qua cac ?ng thong l?n, đ??c chuy?n qua m?t may trao đ?i oxy d?ng mang đ? phan ph?i oxy va lo?i b? carbon dioxide (v?n la cac ch?c n?ng c?a ph?i), r?i đ??c đ?a tr? l?i c? th?. T? ch?c H? tr? S? s?ng Ngoai c? th? (ELSO) co l?u l?i m?t s? k?t qu? co lien quan đ?n cong ngh? nay, ECMO đa đ??c s? d?ng cho h?n 120.000 b?nh nhan t?i 435 trung tam ECMO tren toan th? gi?i v?i t? l? t? vong la 40% đ?i v?i b?nh nhan ho h?p ng??i l?n. [66]

Vi?c s? d?ng ECMO tren b?nh nhan COVID-19 t? Trung Qu?c trong giai đo?n s?m c?a đ?i d?ch thu l?i cac k?t qu? t??ng đ?i kem, v?i t? l? t? vong la tren 90%. [67] Vao thang 3 n?m 2020, b? ph?n d? li?u c?a ELSO b?t đ?u thu th?p d? li?u v? vi?c s? d?ng ECMO tren toan th? gi?i cho b?nh nhan m?c COVID-19 va bao cao d? li?u nay tren trang web ELSO theo th?i gian th?c. Vao thang 9 n?m 2020, k?t qu? c?a 1.035 b?nh nhan COVID-19 đ??c h? tr? ECMO t? 213 trung tam co kinh nghi?m ? 36 qu?c gia khac nhau đa đ??c cong b? tren t?p chi The Lancet , cho th?y t? l? t? vong la 38%, t??ng t? nh? nhi?u b?nh ho h?p khac đ??c đi?u tr? b?ng ECMO. T? l? t? vong c?ng t??ng t? nh? t? l? t? vong 35% đ??c th?y trong th? nghi?m EOLIA , th? nghi?m đ?i ch?ng ng?u nhien l?n nh?t đ?i v?i ECMO tren b?nh nhan co h?i ch?ng suy ho h?p c?p. [68] Cac d? li?u đa c? s?, đa qu?c gia nay cung c?p nh?ng b?ng ch?ng ?ng h? cho vi?c s? d?ng t?m th?i ECMO cho nh?ng b?nh nhan suy ho h?p c?p do gi?m oxy mau lien quan đ?n COVID-19. Do đay la m?t cong ngh? ph?c t?p va co th? gay t?n nhi?u tai nguyen, cac h??ng d?n s? d?ng ECMO trong đ?i d?ch COVID-19 đ??c cong b? va ph? bi?n. [69] [70] [71]

Ng?n ng?a lay truy?n ti?p [ s?a | s?a ma ngu?n ]

Trung tam Ki?m soat va Phong ng?a D?ch b?nh Hoa K? (CDC) khuy?n ngh? b?n b??c đ? ap d?ng PPE. [72]

T? cach ly la bi?n phap đ??c khuy?n ngh? đ?i v?i nh?ng ng??i m?c COVID-19 nh? ho?c nghi ng? minh đa b? nhi?m virus, c? v?i nh?ng ng??i đa bi?u hi?n cac tri?u ch?ng khong đ?c hi?u, nh?m ng?n ng?a s? lay truy?n c?a virus va giup lam gi?m ganh n?ng b?nh nhan cho cac c? s? y t? . [2] T?i V??ng qu?c Anh , vi?c th?c hi?n nh?ng bi?n phap t? cach ly nay đ??c quy đ?nh b?ng lu?t. [73] Cac ch? d?n t? cach cach ly la khac nhau gi?a cac qu?c gia; CDC Hoa K? va D?ch v? Y t? Qu?c gia V??ng qu?c Anh đa ban hanh cac h??ng d?n c? th? v? v?n đ? nay, c?ng nh? nhi?u c? quan đ?a ph??ng co th?m quy?n khac. [73] [74]

Thong khi đ?y đ?, lam s?ch va kh? trung, va x? ly ch?t th?i c?ng r?t c?n thi?t đ? ng?n ng?a chu?i lay nhi?m c?a b?nh. [49]

Cac d?ng c? b?o v? ca nhan [ s?a | s?a ma ngu?n ]

Cac bi?n phap phong ng?a ph?i đ??c th?c hi?n đ? gi?m thi?u nguy c? lay truy?n virus, đ?c bi?t la trong cac c? s? y t? khi th?c hi?n cac bi?n phap co th? t?o ra gi?t b?n , ch?ng h?n nh? đ?t n?i khi qu?n ho?c thong khi b?ng tay. [75] đ?i v?i cac chuyen gia ch?m soc s?c kh?e đang h? tr? cho nh?ng b?nh nhan m?c COVID-19, CDC khuy?n ngh? nen đ?t ng??i đo vao Phong cach ly b?nh lay nhi?m qua đ??ng th? (AIIR) ben c?nh vi?c s? d?ng cac bi?n phap phong ng?a tieu chu?n , phong ng?a ti?p xuc va phong ng?a lay b?nh trong khong khi. [76]

CDC đa đ?a ra cac h??ng d?n v? vi?c s? d?ng thi?t b? b?o v? ca nhan (PPE) trong đ?i d?ch. Thi?t b? đ??c khuy?n ngh? la qu?n ao b?o h?, m?t n? phong đ?c ( respirator ) ho?c kh?u trang , kinh b?o v? m?t va g?ng tay y t? . [77] [78]

Khi co s?n, m?t n? phong đ?c (thay cho kh?u trang) đ??c ?u tien s? d?ng. [79] CDC khuy?n ngh? s? d?ng kh?u trang ? nh?ng n?i cong c?ng, khi khong th? duy tri c? ly gian cach xa h?i, va khi t??ng tac v?i nh?ng ng??i khong cung chung s?ng. [80] M?t n? phong đ?c N95 đ??c ch?p thu?n trong cac c? s? cong nghi?p nh?ng FDA c?ng cho phep s? d?ng cac kh?u trang theo gi?y phep s? d?ng kh?n c?p (EUA). Chung đ??c thi?t k? đ? b?o v? kh?i cac h?t trong khong khi nh? b?i nh?ng hi?u qu? ch?ng l?i m?t tac nhan sinh h?c c? th? la khong đ??c đ?m b?o n?u s? d?ng ngoai cac m?c đich đ??c ghi tren nhan. [81] Khi khong co kh?u trang, CDC khuy?n ngh? s? d?ng t?m che m?t ho?c dung ph??ng an cu?i cung la kh?u trang t? ch? . [82]

H? tr? tam ly [ s?a | s?a ma ngu?n ]

Cac ca nhan co th? g?p ph?i ?c ch? do gian cach xa h?i, h?n ch? di chuy?n, tac d?ng ph? c?a vi?c đi?u tr? ho?c lo l?ng v? vi?c nhi?m b?nh c?a b?n than. đ? gi?i quy?t nh?ng lo ng?i nay, ?y ban Y t? Qu?c gia Trung Qu?c đa xu?t b?n h??ng d?n qu?c gia v? can thi?p kh?ng ho?ng tam ly vao ngay 27 thang 1 n?m 2020. [83] [84]

T?p chi The Lancet đa xu?t b?n m?t l?i keu g?i hanh đ?ng dai 14 trang t?p trung vao V??ng qu?c Anh va neu ro: tinh tr?ng hi?n t?i co th? khi?n cho m?t lo?t cac v?n đ? lien quan đ?n s?c kh?e tam ly tr? nen ph? bi?n h?n. BBC d?n l?i Rory O'Connor noi, "S? gia t?ng trong gian cach xa h?i, s? co đ?n, lo l?ng v? s?c kh?e, c?ng th?ng va suy thoai kinh t? la m?t t? h?p hoan h?o đ? gay t?n h?i đ?n s?c kh?e tinh th?n va h?nh phuc c?a m?i ng??i." [85] [86]

Cac nhom ng??i đ?c bi?t [ s?a | s?a ma ngu?n ]

đi?u tr? đ?ng th?i cac b?nh ly khac [ s?a | s?a ma ngu?n ]

Th?i k? đ?u c?a đ?i d?ch, nh?ng lo ng?i v? ly thuy?t đa đ??c đ?t ra cho vi?c s? d?ng thu?c ?c ch? enzyme chuy?n hoa angiotensin va thu?c khang th? th? angiotensin . Tuy nhien, cac nghien c?u sau đo đa khong tim th?y b?ng ch?ng h? tr? cho vi?c ng?ng s? d?ng cac lo?i thu?c nay ? nh?ng ng??i s? d?ng chung vi m?c cac b?nh nh? huy?t ap cao . [15] [87] [88] [89] M?t nghien c?u t? ngay 22 thang 4 cho th?y nh?ng ng??i co COVID-19 va t?ng huy?t ap co t? l? t? vong do m?i nguyen nhan la th?p h?n khi s? d?ng cac lo?i thu?c nay . [90] M?i quan tam t??ng t? đa đ??c neu ra cho thu?c ch?ng viem khong steroid (NSAID) nh? ibuprofen ; nh?ng nghi ng? nay c?ng khong đ??c ch?ng minh b?ng nghien c?u va cac thu?c NSAID co th? đ??c s? d?ng đ? lam gi?m cac tri?u ch?ng c?a COVID-19 va ti?p t?c đ??c s? d?ng b?i nh?ng ng??i dung chung cho cac b?nh ly khac. [91]

Nh?ng ng??i s? d?ng corticosteroid t?i ch? ho?c toan than cho cac tinh tr?ng ho h?p nh? hen suy?n ho?c b?nh ph?i t?c ngh?n man tinh nen ti?p t?c dung thu?c theo quy đ?nh ngay c? khi h? m?c b?nh COVID-19. [31]

Trong khi mang thai [ s?a | s?a ma ngu?n ]

Cho đ?n nay, h?u h?t cac th? nghi?m lam sang lien quan đ?n SARS-CoV-2 đa lo?i tr? ho?c ch? bao g?m s? it ph? n? mang thai ho?c cho con bu. H?n ch? nay gay kho kh?n cho vi?c đ?a ra cac khuy?n ngh? đi?u tr? d?a tren b?ng ch?ng ? nhom b?nh nhan nay va co th? c?ng gi?i h?n cac hinh th?c đi?u tr? COVID-19 ma h? co th? ch?n. CDC Hoa K? khuy?n ngh?: m?t quy?t đ?nh chung v?i s? tham gia c?a c? b?nh nhan va đ?i ng? lam sang nen đ??c th?c hi?n khi đi?u tr? cho ph? n? mang thai b?ng cac thu?c đang trong qua trinh nghien c?u. [92]

Tham kh?o [ s?a | s?a ma ngu?n ]

  1. ^ a b c d e f Siemieniuk RA, Bartoszko JJ, Ge L, Zeraatkar D, Izcovich A, Kum E, va đ?ng nghi?p (thang 7 n?m 2020). “Drug treatments for covid-19: living systematic review and network meta-analysis” . BMJ . 370 : m2980. doi : 10.1136/bmj.m2980 . PMC   7390912 . PMID   32732190 .
  2. ^ a b c d “Coronavirus” . WebMD . L?u tr? b?n g?c ngay 1 thang 2 n?m 2020 . Truy c?p ngay 1 thang 2 n?m 2020 . "Coronavirus" . WebMD . Archived from the original on 2020-02-01 . Retrieved 2020-02-01 .
  3. ^ Tao, Kaiming; Tzou, Philip L.; Nouhin, Janin; Bonilla, Hector; Jagannathan, Prasanna; Shafer, Robert W. (28 thang 7 n?m 2021). “SARS-CoV-2 Antiviral Therapy”. Clinical Microbiology Reviews : e0010921. doi : 10.1128/CMR.00109-21 . PMID   34319150 .
  4. ^ a b Fisher D, Heymann D (thang 2 n?m 2020). “Q&A: The novel coronavirus outbreak causing COVID-19” . BMC Medicine . 18 (1): 57. doi : 10.1186/s12916-020-01533-w . PMC   7047369 . PMID   32106852 .
  5. ^ Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, va đ?ng nghi?p (thang 5 n?m 2020). “Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province” . Chinese Medical Journal . 133 (9): 1025?1031. doi : 10.1097/CM9.0000000000000744 . PMC   7147277 . PMID   32044814 .
  6. ^ Wang T, Du Z, Zhu F, Cao Z, An Y, Gao Y, Jiang B (thang 3 n?m 2020). “Comorbidities and multi-organ injuries in the treatment of COVID-19” . Lancet . Elsevier BV. 395 (10228): e52. doi : 10.1016/s0140-6736(20)30558-4 . PMC   7270177 . PMID   32171074 .
  7. ^ Wang Y, Wang Y, Chen Y, Qin Q (thang 3 n?m 2020). “Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures” . Journal of Medical Virology . 92 (6): 568?576. doi : 10.1002/jmv.25748 . PMC   7228347 . PMID   32134116 .
  8. ^ Martel J, Ko YF, Young JD, Ojcius DM (thang 5 n?m 2020). “Could nasal breathing help to mitigate the severity of COVID-19” . Microbes and Infection . 22 (4?5): 168?171. doi : 10.1016/j.micinf.2020.05.002 . PMC   7200356 . PMID   32387333 .
  9. ^ “Coronavirus recovery: breathing exercises” . www.hopkinsmedicine.org . Johns Hopkins Medicine . Truy c?p ngay 30 thang 7 n?m 2020 .
  10. ^ Wang L, Wang Y, Ye D, Liu Q (thang 3 n?m 2020). “Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence” . International Journal of Antimicrobial Agents . 55 (6): 105948. doi : 10.1016/j.ijantimicag.2020.105948 . PMC   7156162 . PMID   32201353 .
  11. ^ “What to Do if You Are Sick” . Centers for Disease Control and Prevention (CDC) . 5 thang 4 n?m 2020. L?u tr? b?n g?c ngay 14 thang 2 n?m 2020 . Truy c?p ngay 24 thang 4 n?m 2020 .
  12. ^ “Update to living WHO guideline on drugs for covid-19” . BMJ (Clinical Research Ed.) . 371 : m4475. thang 11 n?m 2020. doi : 10.1136/bmj.m4475 . ISSN   1756-1833 . PMID   33214213 .
  13. ^ “Q&A: Dexamethasone and COVID-19” . World Health Organization (WHO) . Truy c?p ngay 11 thang 7 n?m 2020 .
  14. ^ a b “Home” . National COVID-19 Clinical Evidence Taskforce . B?n g?c l?u tr? ngay 11 thang 10 n?m 2020 . Truy c?p ngay 11 thang 7 n?m 2020 .
  15. ^ a b c d “COVID-19 Treatment Guidelines” . www.nih.gov . National Institutes of Health . Truy c?p ngay 18 thang 1 n?m 2021 . "COVID-19 Treatment Guidelines" . www.nih.gov . National Institutes of Health . Retrieved 2021-01-18 .
  16. ^ a b Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, va đ?ng nghi?p (thang 4 n?m 2020). “Clinical Characteristics of Coronavirus Disease 2019 in China” . The New England Journal of Medicine . Massachusetts Medical Society. 382 (18): 1708?1720. doi : 10.1056/nejmoa2002032 . PMC   7092819 . PMID   32109013 . Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. (April 2020). "Clinical Characteristics of Coronavirus Disease 2019 in China" . The New England Journal of Medicine . Massachusetts Medical Society. 382 (18): 1708?1720. doi : 10.1056/nejmoa2002032 . PMC   7092819 . PMID   32109013 .
  17. ^ Henry BM (thang 4 n?m 2020). “COVID-19, ECMO, and lymphopenia: a word of caution” . The Lancet. Respiratory Medicine . Elsevier BV. 8 (4): e24. doi : 10.1016/s2213-2600(20)30119-3 . PMC   7118650 . PMID   32178774 .
  18. ^ Kim, Jae Seok; Lee, Jun Young; Yang, Jae Won; Lee, Keum Hwa; Effenberger, Maria; Szpirt, Wladimir; Kronbichler, Andreas; Shin, Jae Il (2021). “Immunopathogenesis and treatment of cytokine storm in COVID-19” . Theranostics . 11 (1): 316?329. doi : 10.7150/thno.49713 . PMC   7681075 . PMID   33391477 .
  19. ^ a b Kim PS, Read SW, Fauci AS (thang 12 n?m 2020). “Therapy for Early COVID-19: A Critical Need” . JAMA . American Medical Association (AMA). 324 (21): 2149?2150. doi : 10.1001/jama.2020.22813 . PMID   33175121 .
  20. ^ a b c “COVID-19 Treatment Guidelines” . www.nih.gov . National Institutes of Health . Truy c?p ngay 18 thang 1 n?m 2021 . /
  21. ^ Hsu J (thang 11 n?m 2020). “Covid-19: What now for remdesivir?” . BMJ . 371 : m4457. doi : 10.1136/bmj.m4457 . PMID   33214186 .
  22. ^ “Clinical management of COVID-19” . World Health Organization (WHO) . 27 thang 5 n?m 2020 . Truy c?p ngay 18 thang 1 n?m 2021 .
  23. ^ “Coronavirus (COVID-19) | NICE” . National Institute for Health and Care Excellence . Truy c?p ngay 18 thang 1 n?m 2021 .
  24. ^ Cheng ZJ, Shan J (thang 4 n?m 2020). “2019 Novel coronavirus: where we are and what we know” . Infection . 48 (2): 155?163. doi : 10.1007/s15010-020-01401-y . PMC   7095345 . PMID   32072569 .
  25. ^ Farkas J (thang 3 n?m 2020). COVID-19?The Internet Book of Critical Care (Reference manual). USA: EMCrit. B?n g?c (digital) l?u tr? ngay 11 thang 3 n?m 2020 . Truy c?p ngay 13 thang 3 n?m 2020 .
  26. ^ “COVID19?Resources for Health Care Professionals” . Penn Libraries . 11 thang 3 n?m 2020. L?u tr? b?n g?c ngay 14 thang 3 n?m 2020 . Truy c?p ngay 13 thang 3 n?m 2020 .
  27. ^ Guo, Wenjing; Pan, Bohu; Sakkiah, Sugunadevi; Ji, Zuowei; Yavas, Gokhan; Lu, Yanhui; Komatsu, Takashi E.; Lal-Nag, Madhu; Tong, Weida (thang 12 n?m 2021). “Informing selection of drugs for COVID-19 treatment through adverse events analysis” . Scientific Reports . 11 (1): 14022. doi : 10.1038/s41598-021-93500-5 . PMC   8263777 . PMID   34234253 .
  28. ^ “COVID-19 Frequently Asked Questions: Drugs (Medicines)” . U.S. Food and Drug Administration . 19 thang 2 n?m 2021 . Truy c?p ngay 20 thang 2 n?m 2021 .
  29. ^ “Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab” (Thong cao bao chi). 16 thang 4 n?m 2021 . Truy c?p ngay 16 thang 4 n?m 2021 . Phạm vi công cộng  Bai vi?t nay tich h?p v?n b?n t? ngu?n nay, v?n thu?c ph?m vi cong c?ng .
  30. ^ “Treatments and vaccines for COVID-19: authorised medicines” . European Medicines Agency . Truy c?p ngay 20 thang 2 n?m 2021 .
  31. ^ a b “Australian guidelines for the clinical care of people with COVID-19” . National COVID-19 Clinical Evidence Taskforce . National COVID-19 Clinical Evidence Taskforce . Truy c?p ngay 11 thang 7 n?m 2020 . "Australian guidelines for the clinical care of people with COVID-19" . National COVID-19 Clinical Evidence Taskforce . National COVID-19 Clinical Evidence Taskforce . Retrieved 11 July 2020 .
  32. ^ Rizk JG, Kalantar-Zadeh K, Mehra MR, Lavie CJ, Rizk Y, Forthal DN (thang 9 n?m 2020). “Pharmaco-Immunomodulatory Therapy in COVID-19” . Drugs . Springer. 80 (13): 1267?1292. doi : 10.1007/s40265-020-01367-z . PMC   7372203 . PMID   32696108 .
  33. ^ Frohman EM, Villemarette-Pittman NR, Rodriguez A, Glanzman R, Rugheimer S, Komogortsev O, va đ?ng nghi?p (thang 7 n?m 2021). “Application of an evidence-based, out-patient treatment strategy for COVID-19: Multidisciplinary medical practice principles to prevent severe disease” . Journal of the Neurological Sciences . 426 : 117463. doi : 10.1016/j.jns.2021.117463 . PMC   8055502 . PMID   33971376 .
  34. ^ Viswanatha GL, Anjana Male CK, Shylaja H (thang 7 n?m 2021). “Efficacy and safety of tocilizumab in the management of COVID-19: a systematic review and meta-analysis of observational studies”. Clinical and Experimental Rheumatology . PMID   34251307 .
  35. ^ Shang L, Lye DC, Cao B (thang 7 n?m 2021). “Contemporary narrative review of treatment options for COVID-19” . Respirology (Carlton, Vic.) . 26 (8): 745?767. doi : 10.1111/resp.14106 . PMID   34240518 .
  36. ^ a b Dominus, Susan (5 thang 8 n?m 2020). “The Covid Drug Wars That Pitted Doctor vs. Doctor” . The New York Times .
  37. ^ a b Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB (thang 5 n?m 2020). “Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review” . JAMA . 323 (18): 1824?1836. doi : 10.1001/jama.2020.6019 . PMID   32282022 .
  38. ^ Piechotta, Vanessa; Iannizzi, Claire; Chai, Khai Li; Valk, Sarah J.; Kimber, Catherine; Dorando, Elena; Monsef, Ina; Wood, Erica M.; Lamikanra, Abigail A. (20 thang 5 n?m 2021). “Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review” . The Cochrane Database of Systematic Reviews . 2021 (5): CD013600. doi : 10.1002/14651858.CD013600.pub4 . ISSN   1469-493X . PMC   8135693 . PMID   34013969 .
  39. ^ Abani O, Abbas A, Abbas F, Abbas M, Abbasi S, Abbass H, va đ?ng nghi?p (thang 5 n?m 2021). “Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial” . Lancet . 397 (10289): 2049?2059. doi : 10.1016/S0140-6736(21)00897-7 . PMC   8121538 . PMID   34000257 .
  40. ^ McCreary EK, Pogue JM (thang 4 n?m 2020). “Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options” . Open Forum Infectious Diseases . 7 (4): ofaa105. doi : 10.1093/ofid/ofaa105 . PMC   7144823 . PMID   32284951 .
  41. ^ “Chinese doctors using plasma therapy on coronavirus, WHO says 'very valid' approach” . Reuters . 17 thang 2 n?m 2020. L?u tr? b?n g?c ngay 4 thang 3 n?m 2020 . Truy c?p ngay 19 thang 3 n?m 2020 .
  42. ^ “With Wuhan virus genetic code in hand, scientists begin work on a vaccine” . Reuters . 24 thang 1 n?m 2020. L?u tr? b?n g?c ngay 25 thang 1 n?m 2020 . Truy c?p ngay 25 thang 1 n?m 2020 .
  43. ^ “Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19” . clinicaltrialsarena.com . 19 thang 2 n?m 2020. B?n g?c l?u tr? ngay 19 thang 2 n?m 2020.
  44. ^ Lu H (thang 3 n?m 2020). “Drug treatment options for the 2019-new coronavirus (2019-nCoV)” . Bioscience Trends . 14 (1): 69?71. doi : 10.5582/bst.2020.01020 . PMID   31996494 .
  45. ^ Li G, De Clercq E (thang 3 n?m 2020). “Therapeutic options for the 2019 novel coronavirus (2019-nCoV)” . Nature Reviews. Drug Discovery . 19 (3): 149?150. doi : 10.1038/d41573-020-00016-0 . PMID   32127666 .
  46. ^ “WHO: 'no known effective' treatments for new coronavirus” . Thomson Reuters . 5 thang 2 n?m 2020. L?u tr? b?n g?c ngay 5 thang 2 n?m 2020 . Truy c?p ngay 5 thang 2 n?m 2020 .
  47. ^ a b “FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19” (Thong cao bao chi). 10 thang 2 n?m 2021 . Truy c?p ngay 9 thang 2 n?m 2021 . Phạm vi công cộng  Bai vi?t nay tich h?p v?n b?n t? ngu?n nay, v?n thu?c ph?m vi cong c?ng .
  48. ^ a b “Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19” . U.S. Food and Drug Administration (FDA) . 23 thang 11 n?m 2020 . Truy c?p ngay 17 thang 4 n?m 2021 . Phạm vi công cộng  Bai vi?t nay tich h?p v?n b?n t? ngu?n nay, v?n thu?c ph?m vi cong c?ng .
  49. ^ a b “Home care for patients with suspected or confirmed COVID-19 and management of their contacts” (PDF) . World Health Organization (WHO) . 13 thang 8 n?m 2020 . Truy c?p ngay 18 thang 1 n?m 2021 . "Home care for patients with suspected or confirmed COVID-19 and management of their contacts" (PDF) . World Health Organization (WHO) . 2020-08-13 . Retrieved 2021-01-18 .
  50. ^ “Overview of novel coronavirus (2019-nCoV)?Summary of relevant conditions” . The BMJ . L?u tr? b?n g?c ngay 31 thang 1 n?m 2020 . Truy c?p ngay 1 thang 2 n?m 2020 .
  51. ^ Janik E, Niemcewicz M, Podogrocki M, Saluk-Bijak J, Bijak M. Existing Drugs Considered as Promising in COVID-19 Therapy. Int J Mol Sci . 2021 May 21;22(11):5434. doi : 10.3390/ijms22115434 PMID   34063964
  52. ^ Hall K, Mfone F, Shallcross M, Pathak V. Review of Pharmacotherapy Trialed for Management of the Coronavirus Disease-19. Eurasian J Med . 2021 Jun;53(2):137-143. doi : 10.5152/eurasianjmed.2021.20384 PMID   34177298
  53. ^ Heustess AM, Allard MA, Thompson DK, Fasinu PS. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options. Pharmaceuticals (Basel) . 2021 May 28;14(6):520. doi : 10.3390/ph14060520 PMID   34071185
  54. ^ a b c Murthy S, Gomersall CD, Fowler RA (thang 3 n?m 2020). “Care for Critically Ill Patients With COVID-19” . JAMA . 323 (15): 1499?1500. doi : 10.1001/jama.2020.3633 . PMID   32159735 . B?n g?c l?u tr? ngay 18 thang 3 n?m 2020 . Truy c?p ngay 18 thang 3 n?m 2020 . Murthy S, Gomersall CD, Fowler RA (March 2020). "Care for Critically Ill Patients With COVID-19" . JAMA . 323 (15): 1499?1500. doi : 10.1001/jama.2020.3633 . PMID   32159735 . Archived from the original on 18 March 2020 . Retrieved 18 March 2020 .
  55. ^ a b Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand (B?n bao cao). Imperial College London . 16 thang 3 n?m 2020. doi : 10.25561/77482 . B?n g?c l?u tr? ngay 21 thang 3 n?m 2020 . Truy c?p ngay 25 thang 3 n?m 2020 .
  56. ^ “Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected” (PDF) . World Health Organization (WHO). 28 thang 1 n?m 2020. L?u tr? (PDF) b?n g?c ngay 26 thang 2 n?m 2020 . Truy c?p ngay 18 thang 3 n?m 2020 .
  57. ^ Wang K, Zhao W, Li J, Shu W, Duan J (thang 3 n?m 2020). “The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China” . Annals of Intensive Care . 10 (1): 37. doi : 10.1186/s13613-020-00653-z . PMC   7104710 . PMID   32232685 .
  58. ^ McEnery T, Gough C, Costello RW (thang 4 n?m 2020). “COVID-19: Respiratory support outside the intensive care unit” . The Lancet. Respiratory Medicine . 8 (6): 538?539. doi : 10.1016/S2213-2600(20)30176-4 . PMC   7146718 . PMID   32278367 .
  59. ^ Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, va đ?ng nghi?p (thang 6 n?m 2020). “Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study” . The Lancet . 395 (10239): 1763?70. doi : 10.1016/S0140-6736(20)31189-2 . PMC   7237188 . PMID   32442528 .
  60. ^ a b “Coronavirus is exposing all of the weaknesses in the US health system High health care costs and low medical capacity made the US uniquely vulnerable to the coronavirus” . Vox. 16 thang 3 n?m 2020. L?u tr? b?n g?c ngay 18 thang 3 n?m 2020 . Truy c?p ngay 18 thang 3 n?m 2020 .
  61. ^ “Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)” . Centers for Disease Control and Prevention (CDC) . 6 thang 4 n?m 2020. L?u tr? b?n g?c ngay 2 thang 3 n?m 2020 . Truy c?p ngay 19 thang 4 n?m 2020 .
  62. ^ Alhazzani W, Møller MH, Arabi YM, Loeb M, Gong MN, Fan E, va đ?ng nghi?p (thang 5 n?m 2020). “Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)” . Intensive Care Med (Clinical practice guideline). 46 (5): 854?887. doi : 10.1007/s00134-020-06022-5 . PMC   7101866 . PMID   32222812 .
  63. ^ Matthay MA, Aldrich JM, Gotts JE (thang 5 n?m 2020). “Treatment for severe acute respiratory distress syndrome from COVID-19” . The Lancet. Respiratory Medicine . 8 (5): 433?434. doi : 10.1016/S2213-2600(20)30127-2 . PMC   7118607 . PMID   32203709 .
  64. ^ Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, va đ?ng nghi?p (thang 3 n?m 2010). “Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis” . JAMA . 303 (9): 865?73. doi : 10.1001/jama.2010.218 . PMID   20197533 .
  65. ^ Diaz R, Heller D (2020). Barotrauma And Mechanical Ventilation . StatPearls . StatPearls Publishing. PMID   31424810 .
  66. ^ “Extracorporeal Life Support Organization - ECMO and ECLS > Registry > Statistics > International Summary” . www.elso.org . Truy c?p ngay 28 thang 9 n?m 2020 .
  67. ^ Henry BM, Lippi G (thang 8 n?m 2020). “Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports” . Journal of Critical Care . 58 : 27?8. doi : 10.1016/j.jcrc.2020.03.011 . PMC   7118619 . PMID   32279018 .
  68. ^ Combes A, Hajage D, Capellier G, Demoule A, Lavoue S, Guervilly C, va đ?ng nghi?p (thang 5 n?m 2018). “Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome” . New England Journal of Medicine . 378 (21): 1965?75. doi : 10.1056/NEJMoa1800385 . PMID   29791822 .
  69. ^ Bartlett RH, Ogino MT, Brodie D, McMullan DM, Lorusso R, MacLaren G, va đ?ng nghi?p (thang 5 n?m 2020). “Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure” . ASAIO Journal . 66 (5): 472?4. doi : 10.1097/MAT.0000000000001173 . PMC   7273858 . PMID   32243267 .
  70. ^ Shekar K, Badulak J, Peek G, Boeken U, Dalton HJ, Arora L, va đ?ng nghi?p (thang 7 n?m 2020). “Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers” . ASAIO Journal . 66 (7): 707?21. doi : 10.1097/MAT.0000000000001193 . PMC   7228451 . PMID   32358233 .
  71. ^ Ramanathan K, Antognini D, Combes A, Paden M, Zakhary B, Ogino M, va đ?ng nghi?p (thang 5 n?m 2020). “Planning and provision of ECMO services for severe ARDS during the COVID-19 pandemic and other outbreaks of emerging infectious diseases” . The Lancet Respiratory Medicine . 8 (5): 518?26. doi : 10.1016/s2213-2600(20)30121-1 . PMC   7102637 . PMID   32203711 .
  72. ^ “Sequence for Putting On Personal Protective Equipment (PPE)” (PDF) . Centers for Disease Control and Prevention (CDC) . L?u tr? (PDF) b?n g?c ngay 5 thang 3 n?m 2020 . Truy c?p ngay 8 thang 3 n?m 2020 .
  73. ^ a b “When to self-isolate and what to do - Coronavirus (COVID-19)” . NHS. 8 thang 1 n?m 2021 . Truy c?p ngay 18 thang 1 n?m 2021 .
  74. ^ “Isolate If You Are Sick” . CDC . 7 thang 1 n?m 2021 . Truy c?p ngay 18 thang 1 n?m 2021 .
  75. ^ Cheung JC, Ho LT, Cheng JV, Cham EY, Lam KN (thang 4 n?m 2020). “Staff safety during emergency airway management for COVID-19 in Hong Kong” . The Lancet. Respiratory Medicine . 8 (4): e19. doi : 10.1016/s2213-2600(20)30084-9 . PMC   7128208 . PMID   32105633 .
  76. ^ “What healthcare personnel should know about caring for patients with confirmed or possible coronavirus disease 2” (PDF) . Centers for Disease Control and Prevention (CDC) . 12 thang 3 n?m 2020 . Truy c?p ngay 31 thang 3 n?m 2020 .
  77. ^ “Coronavirus Disease 2019 (COVID-19)” . Centers for Disease Control and Prevention (CDC) . 11 thang 2 n?m 2020. L?u tr? b?n g?c ngay 4 thang 3 n?m 2020 . Truy c?p ngay 11 thang 3 n?m 2020 .
  78. ^ “Coronavirus Disease 2019 (COVID-19)” . Centers for Disease Control and Prevention (CDC) . 11 thang 2 n?m 2020. L?u tr? b?n g?c ngay 4 thang 3 n?m 2020 . Truy c?p ngay 8 thang 3 n?m 2020 .
  79. ^ “Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings” . Centers for Disease Control and Prevention (CDC) . 11 thang 2 n?m 2020. L?u tr? b?n g?c ngay 4 thang 3 n?m 2020 . Truy c?p ngay 25 thang 3 n?m 2020 .
  80. ^ CDC (11 thang 2 n?m 2020). “Coronavirus Disease 2019 (COVID-19)” . Centers for Disease Control and Prevention . Truy c?p ngay 30 thang 7 n?m 2020 .
  81. ^ “Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions” . Food and Drug Administration .
  82. ^ “Strategies for Optimizing the Supply of Facemasks” . Centers for Disease Control and Prevention (CDC). 11 thang 2 n?m 2020. L?u tr? b?n g?c ngay 23 thang 3 n?m 2020 . Truy c?p ngay 23 thang 3 n?m 2020 .
  83. ^ Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, Ng CH (thang 3 n?m 2020). “Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed” . The Lancet. Psychiatry . 7 (3): 228?229. doi : 10.1016/S2215-0366(20)30046-8 . PMC   7128153 . PMID   32032543 .
  84. ^ Kang L, Li Y, Hu S, Chen M, Yang C, Yang BX, va đ?ng nghi?p (thang 3 n?m 2020). “The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus” . The Lancet. Psychiatry . 7 (3): e14. doi : 10.1016/S2215-0366(20)30047-X . PMC   7129673 . PMID   32035030 .
  85. ^ Coronavirus: 'Profound' mental health impact prompts calls for urgent research , BBC, Philippa Roxby, 16 April 2020.
  86. ^ Multidisciplinary research priorities for the COVID?19 pandemic: a call for action for mental health science , The Lancet , Emily Holmes, Rory O'Connor, Hugh Perry, et al., 15 April 2020, page 1: "A fragmented research response, characterised by small-scale and localised initiatives, will not yield the clear insights necessary to guide policymakers or the public."
  87. ^ “Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician” . B?n g?c l?u tr? ngay 21 thang 3 n?m 2020 . Truy c?p ngay 21 thang 3 n?m 2020 .
  88. ^ “Patients taking ACE-i and ARBs who contract COVID-19 should continue treatment, unless otherwise advised by their physician” (Thong cao bao chi). 17 thang 3 n?m 2020. B?n g?c l?u tr? ngay 24 thang 3 n?m 2020 . Truy c?p ngay 25 thang 3 n?m 2020 .
  89. ^ “Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers” . Council on Hypertension of the European Society of Cardiology . L?u tr? b?n g?c ngay 24 thang 3 n?m 2020 . Truy c?p ngay 24 thang 3 n?m 2020 .
  90. ^ “New Evidence Concerning Safety of ACE Inhibitors, ARBs in COVID-19” . Pharmacy Times . B?n g?c l?u tr? ngay 11 thang 10 n?m 2020 . Truy c?p ngay 2 thang 5 n?m 2020 .
  91. ^ “FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19” . U.S. Food and Drug Administration (FDA). 19 thang 3 n?m 2020. L?u tr? b?n g?c ngay 27 thang 3 n?m 2020 . Truy c?p ngay 27 thang 3 n?m 2020 .
  92. ^ “Coronavirus Disease 2019 (COVID-19) Treatment Guidelines” (PDF) . CDC . Centers for Disease control and Prevention . Truy c?p ngay 12 thang 11 n?m 2020 . Phạm vi công cộng  Bai vi?t nay tich h?p v?n b?n t? ngu?n nay, v?n thu?c ph?m vi cong c?ng .